Journal article
Influence of Body Mass Index on Survival in Veterans With Multiple Myeloma
The oncologist (Dayton, Ohio), Vol.18(10), pp.1074-1079
10/2013
DOI: 10.1634/theoncologist.2013-0015
PMCID: PMC3805147
PMID: 24048366
Abstract
This investigation of the association between body mass index at the time of multiple myeloma diagnosis and overall survival in a cohort of patients within the Veterans Health Administration system showed that disease-related weight loss may be an important and heretofore unknown indicator of poor prognosis in multiple myeloma. Weight loss ≥10% of baseline in the year before diagnosis was associated with significantly increased mortality.
Describe the association between baseline BMI, weight loss, and survival in MM.
Explain the importance of BMI and baseline weight loss as part of the standard history obtained in patients with MM.
Details
- Title: Subtitle
- Influence of Body Mass Index on Survival in Veterans With Multiple Myeloma
- Creators
- Tracey S Beason - Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USASu-Hsin Chang - Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USAKristen M Sanfilippo - Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USASuhong Luo - Research Service, St. Louis Veterans Affairs Medical Center, St. Louis, Missouri, USAGraham A Colditz - Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USARavi Vij - Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USAMichael H Tomasson - Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USAJohn F Dipersio - Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USAKeith Stockerl-Goldstein - Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USAArun Ganti - Research Service, St. Louis Veterans Affairs Medical Center, St. Louis, Missouri, USATanya Wildes - Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USAKenneth R Carson - Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
- Resource Type
- Journal article
- Publication Details
- The oncologist (Dayton, Ohio), Vol.18(10), pp.1074-1079
- Publisher
- AlphaMed Press
- DOI
- 10.1634/theoncologist.2013-0015
- PMID
- 24048366
- PMCID
- PMC3805147
- ISSN
- 1083-7159
- eISSN
- 1549-490X
- Grant note
- DOI: 10.13039/100007338, name: Barnes-Jewish Hospital Foundation; name: American Cancer Society Grant, award: IRG 58–010-52; DOI: 10.13039/100000054, name: National Cancer Institute; DOI: 10.13039/100000002, name: National Institutes of Health, award: U54CA155496, KM1CA15608
- Language
- English
- Date published
- 10/2013
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984094505802771
Metrics
14 Record Views